Rare diseases
Investigational molecules
Locations
Study on the Long-Term Safety and Effectiveness of Ozanimod for Adults with Moderate to Severe Ulcerative Colitis
HungaryStudy on BI 1839100 for Reducing Cough in Patients with Idiopathic or Progressive Pulmonary Fibrosis
HungaryStudy on Remibrutinib for Adults with Chronic Inducible Urticaria Uncontrolled by H1-Antihistamines
HungaryStudy on the Long-Term Safety of Pimavanserin for Treating Irritability in Children and Adolescents with Autism Spectrum Disorder
HungaryStudy of petosemtamab with pembrolizumab compared to pembrolizumab alone in patients with head and neck cancer who have not received previous treatment for advanced disease
HungaryStudy of petosemtamab compared to standard therapy in previously treated patients with metastatic or recurrent head and neck cancer
HungaryStudy of OPT-302 and Aflibercept for Patients with Wet Age-related Macular Degeneration
HungaryStudy on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis
HungaryStudy of Domvanalimab, Zimberelimab, and Chemotherapy for Patients with Advanced Esophageal or Gastric Cancer
HungaryStudy on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy
HungaryStudy on the Effectiveness and Safety of Sonelokimab for Adults with Moderate to Severe Hidradenitis Suppurativa
HungaryLong-term safety study of filgotinib tablets in adults with ulcerative colitis who completed previous filgotinib treatment
HungaryTell us about your condition – we search every trial in Europe and connect you with the right site.
